The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2016

Filed:

Jan. 12, 2016
Applicant:

Zyomed Corp., Altadena, CA (US);

Inventors:

Sandeep Gulati, La Canada Flintridge, CA (US);

Timothy L. Ruchti, Gurnee, IL (US);

William Van Antwerp, Valencia, CA (US);

John L. Smith, Portland, OR (US);

Assignee:

Zyomed, Corp., Altadena, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01J 5/02 (2006.01); G01N 21/3577 (2014.01); A61B 5/024 (2006.01); G01N 21/359 (2014.01); G01N 21/47 (2006.01); G01N 21/49 (2006.01); G01N 33/49 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61B 5/1455 (2006.01); A61B 5/1495 (2006.01);
U.S. Cl.
CPC ...
G01N 21/3577 (2013.01); A61B 5/0075 (2013.01); A61B 5/024 (2013.01); A61B 5/02416 (2013.01); A61B 5/1455 (2013.01); A61B 5/1495 (2013.01); A61B 5/14532 (2013.01); A61B 5/7203 (2013.01); A61B 5/7235 (2013.01); A61B 5/7264 (2013.01); G01N 21/359 (2013.01); G01N 21/4795 (2013.01); G01N 21/49 (2013.01); G01N 33/49 (2013.01); A61B 5/7253 (2013.01); A61B 5/7267 (2013.01); A61B 2560/0223 (2013.01); G01N 2201/062 (2013.01); G01N 2201/12 (2013.01); G01N 2201/129 (2013.01);
Abstract

A synthetic projection system determines analyte concentration, such as blood glucose concentration, from a spectral-energy change associated with an uncharacterized instance of a medium in which the analyte is likely present. The projection system is factory calibrated for different instances of the medium, without needing instance-specific training or calibration. The projection system includes a set of projector curves, each relating spectral-energy change values obtained by analyzing reference medium samples to analyte concentrations in those samples. Each projector curve also corresponds to a respective range of energy-change gradients, determined using a group of surrogate media characterized according to analyte concentrations measured using a reference system. A spectral-energy-change gradient for the uncharacterized medium may be computed to select one of the projectors curves. Analyte concentration in the uncharacterized medium can be reliably computed at a specified high level of accuracy using the spectral-energy change associated therewith and the selected curve.


Find Patent Forward Citations

Loading…